Xtrackers Russell US Multifactor ETF (DEUS) Chart & Stock Price History → Could this Tiny Biotech End Disease Forever? (From Behind the Markets) (Ad) Free DEUS Stock Alerts $50.37 -0.03 (-0.06%) (As of 10:06 AM ET) Add Compare Share Share ChartStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings Xtrackers Russell US Multifactor ETF Stock Price Performance5 Day Performance+1.29%1 Month Performance-2.19%3 Month Performance+3.66%6 Month Performance+17.17%Year-To-Date Performance+5.79%1 Year Performance+18.11% Receive DEUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Xtrackers Russell US Multifactor ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsThe Weight Loss Pill That Could Disrupt a $32 Billion IndustryA revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.Don't miss out on the "next Ozempic" >>> DEUS Stock Chart for Wednesday, May, 8, 2024 DEUS Chart by TradingView Xtrackers Russell US Multifactor ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$50.21$50.40+0.38%$50.45$50.344,396 shs$153.72 million05/06/2024$49.73$50.21+0.97%$50.21$50.033,910 shs$153.14 million05/03/2024$49.30$49.73+0.87%$49.96$49.683,534 shs$151.67 million05/02/2024$49.03$49.30+0.55%$49.36$49.014,560 shs$150.37 million05/01/2024$49.22$49.03-0.39%$49.21$48.923,812 shs$149.54 million04/30/2024$50.04$49.22-1.64%$49.98$49.223,705 shs$150.13 million Get the Latest News and Ratings for DEUS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Xtrackers Russell US Multifactor ETF and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$49.83$50.04+0.41%$50.04$49.887,895 shs$152.62 million04/26/2024$49.67$49.83+0.32%$49.91$49.807,442 shs$151.98 million04/25/2024$49.85$49.67-0.36%$49.82$49.254,287 shs$151.49 million04/24/2024$49.77$49.85+0.16%$49.92$49.624,522 shs$152.04 million04/23/2024$49.32$49.77+0.91%$49.90$49.306,247 shs$151.80 million04/22/2024$48.99$49.32+0.67%$49.42$49.057,020 shs$150.43 million04/19/2024$48.93$48.96+0.06%$49.18$48.919,447 shs$149.33 million04/18/2024$49.12$48.93-0.39%$49.38$48.913,003 shs$146.79 million04/17/2024$49.41$49.12-0.58%$49.60$49.054,803 shs$147.36 million04/16/2024$49.60$49.41-0.39%$49.58$49.205,479 shs$148.22 million04/15/2024$50.01$49.60-0.82%$50.36$49.454,798 shs$148.80 million04/12/2024$50.76$50.01-1.48%$50.53$49.923,612 shs$150.03 million04/11/2024$50.76$50.76$50.85$50.4211,127 shs$152.28 million04/10/2024$51.50$50.76-1.44%$50.78$50.598,735 shs$152.28 million04/09/2024$51.50$51.50$51.67$51.138,965 shs$154.50 million04/08/2024$51.41$51.50+0.18%$51.65$51.487,813 shs$154.50 million04/05/2024$51.06$51.41+0.69%$51.52$51.168,411 shs$154.23 million04/04/2024$51.58$51.06-1.01%$51.92$50.9612,331 shs$153.18 million04/03/2024$51.41$51.58+0.33%$51.67$51.4615,773 shs$154.74 million04/02/2024$51.91$51.41-0.97%$51.41$51.218,216 shs$154.23 million04/01/2024$52.17$51.91-0.49%$52.13$51.8210,049 shs$155.73 million03/29/2024$52.13$52.17+0.07%$52.20$52.0413,831 shs$156.50 million03/28/2024$51.96$52.13+0.33%$52.20$52.0413,831 shs$156.39 million03/27/2024$51.36$51.96+1.17%$51.96$51.5625,955 shs$155.88 million03/26/2024$51.37$51.36-0.02%$51.53$51.364,957 shs$154.08 million03/25/2024$51.56$51.37-0.37%$51.56$51.377,949 shs$154.11 million03/22/2024$51.81$51.56-0.48%$51.86$51.512,475 shs$154.68 million03/21/2024$51.33$51.81+0.94%$51.83$51.381,923 shs$155.43 million03/20/2024$50.88$51.33+0.88%$51.38$50.854,492 shs$153.99 million03/19/2024$50.49$50.88+0.77%$50.88$50.564,481 shs$152.64 million03/18/2024$50.44$50.49+0.10%$50.69$50.493,152 shs$151.47 million03/15/2024$50.63$50.44-0.37%$50.59$50.433,583 shs$151.32 million03/14/2024$51.02$50.63-0.77%$51.00$50.499,097 shs$151.88 million03/13/2024$51.00$51.02+0.05%$51.20$50.977,722 shs$153.06 millionCould this Tiny Biotech End Disease Forever? (Ad)Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.Access my full "Cut & Paste" profit analysis now.03/12/2024$50.69$51.00+0.60%$51.04$50.748,767 shs$152.99 million03/11/2024$50.74$50.69-0.10%$50.75$50.425,746 shs$152.07 million03/08/2024$50.99$51.13+0.27%$51.15$50.8011,444 shs$153.39 million03/07/2024$50.52$50.99+0.93%$51.06$50.844,072 shs$152.97 million03/06/2024$50.21$50.52+0.62%$50.69$50.416,904 shs$151.56 million03/05/2024$50.52$50.21-0.61%$50.54$50.045,785 shs$150.63 million03/04/2024$50.40$50.52+0.24%$50.67$50.5210,462 shs$151.56 million03/01/2024$50.09$50.40+0.62%$50.40$50.047,641 shs$151.20 million02/29/2024$49.81$50.09+0.56%$50.18$49.9012,763 shs$150.27 million02/28/2024$49.81$49.81$49.87$49.6310,157 shs$149.43 million02/27/2024$49.71$49.81+0.20%$49.86$49.682,916 shs$149.43 million02/26/2024$49.80$49.71-0.18%$49.89$49.7113,156 shs$149.13 million02/23/2024$49.56$49.80+0.49%$49.80$49.6113,303 shs$149.40 million02/22/2024$48.87$49.56+1.41%$49.57$49.274,386 shs$148.67 million02/21/2024$48.71$48.87+0.33%$48.87$48.6915,239 shs$146.61 million02/20/2024$48.92$48.71-0.43%$48.83$48.6929,578 shs$146.13 million02/19/2024$48.92$48.92+0.01%$49.26$48.922,500 shs$146.76 million02/16/2024$49.19$48.92-0.55%$49.26$48.922,547 shs$146.76 million02/15/2024$48.73$49.19+0.94%$49.20$49.032,881 shs$147.57 million02/14/2024$48.13$48.73+1.25%$48.74$48.409,963 shs$146.19 million02/13/2024$49.01$48.13-1.80%$48.39$47.995,367 shs$144.39 million02/12/2024$48.84$49.01+0.35%$49.09$48.803,454 shs$147.03 million02/09/2024$48.59$48.78+0.39%$48.84$48.635,557 shs$146.34 million02/08/2024$48.38$48.59+0.44%$48.59$48.506,704 shs$145.77 million02/07/2024$48.07$48.38+0.64%$48.52$48.153,999 shs$145.13 million Related Companies: SIXL Stock Price Chart HEQT Stock Price Chart XCOR Stock Price Chart SPUU Stock Price Chart AZBO Stock Price Chart ONEO Stock Price Chart DVAL Stock Price Chart BBLU Stock Price Chart CAML Stock Price Chart WEBL Stock Price Chart Receive DEUS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Xtrackers Russell US Multifactor ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:DEUS) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward PressAI “wealth window” is closing June 25thParadigm PressClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xtrackers Russell US Multifactor ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.